Your browser doesn't support javascript.
loading
Whole blood coagulation in an ex vivo thrombus is sufficient to induce clot neutrophils to adopt a myeloid-derived suppressor cell signature and shed soluble Lox-1.
Leonard, Julia; Kepplinger, David; Espina, Virginia; Gillevet, Pat; Ke, Yunbo; Birukov, Konstantin G; Doctor, Allan; Hoemann, Caroline D.
Afiliação
  • Leonard J; Department of Bioengineering, Institute of Biomedical Engineering, George Mason University, Manassas, Virginia, USA.
  • Kepplinger D; Department of Statistics, George Mason University, Fairfax, Virginia, USA.
  • Espina V; Department of Systems Biology, George Mason University, Fairfax, Virginia, USA.
  • Gillevet P; Department of Biology, George Mason University, Fairfax, Virginia, USA.
  • Ke Y; Department of Anesthesiology, School of Medicine, University of Maryland at Baltimore, Baltimore, Maryland, USA.
  • Birukov KG; Department of Anesthesiology, School of Medicine, University of Maryland at Baltimore, Baltimore, Maryland, USA.
  • Doctor A; Departments of Pediatrics & Bioengineering and Center for Blood Oxygen Transport and Hemostasis, School of Medicine, University of Maryland at Baltimore, Baltimore, Maryland, USA.
  • Hoemann CD; Department of Bioengineering, Institute of Biomedical Engineering, George Mason University, Manassas, Virginia, USA. Electronic address: choemann@gmu.edu.
J Thromb Haemost ; 22(4): 1031-1045, 2024 Apr.
Article em En | MEDLINE | ID: mdl-38135253
ABSTRACT

BACKGROUND:

Blood clots are living tissues that release inflammatory mediators including IL-8/CXCL8 and MCP-1/CCL2. A deeper understanding of blood clots is needed to develop new therapies for prothrombotic disease states and regenerative medicine.

OBJECTIVES:

To identify a common transcriptional shift in cultured blood clot leukocytes.

METHODS:

Differential gene expression of whole blood and cultured clots (4 hours at 37 °C) was assessed by RNA sequencing (RNAseq), reverse transcriptase-polymerase chain reaction, proteomics, and histology (23 diverse healthy human donors). Cultured clot serum bioactivity was tested in endothelial barrier functional assays.

RESULTS:

All cultured clots developed a polymorphonuclear myeloid-derived suppressor cell (PMN-MDSC) signature, including up-regulation of OLR1 (mRNA encoding lectin-like oxidized low-density lipoprotein receptor 1 [Lox-1]), IL-8/CXCL8, CXCL2, CCL2, IL10, IL1A, SPP1, TREM1, and DUSP4/MKP. Lipopolysaccharide enhanced PMN-MDSC gene expression and specifically induced a type II interferon response with IL-6 production. Lox-1 was specifically expressed by cultured clot CD15+ neutrophils. Cultured clot neutrophils, but not activated platelets, shed copious amounts of soluble Lox-1 (sLox-1) with a donor-dependent amplitude. sLox-1 shedding was enhanced by phorbol ester and suppressed by heparin and by beta-glycerol phosphate, a phosphatase inhibitor. Cultured clot serum significantly enhanced endothelial cell monolayer barrier function, consistent with a proresolving bioactivity.

CONCLUSION:

This study suggests that PMN-MDSC activation is part of the innate immune response to coagulation which may have a protective role in inflammation. The cultured blood clot is an innovative thrombus model that can be used to study both sterile and nonsterile inflammatory states and could be used as a personalized medicine tool for drug screening.
Assuntos
Palavras-chave

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Trombose / Células Supressoras Mieloides Limite: Humans Idioma: En Revista: J Thromb Haemost Assunto da revista: HEMATOLOGIA Ano de publicação: 2024 Tipo de documento: Article País de afiliação: Estados Unidos

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Trombose / Células Supressoras Mieloides Limite: Humans Idioma: En Revista: J Thromb Haemost Assunto da revista: HEMATOLOGIA Ano de publicação: 2024 Tipo de documento: Article País de afiliação: Estados Unidos